TH79776A - - Google Patents

Info

Publication number
TH79776A
TH79776A TH401001654A TH0401001654A TH79776A TH 79776 A TH79776 A TH 79776A TH 401001654 A TH401001654 A TH 401001654A TH 0401001654 A TH0401001654 A TH 0401001654A TH 79776 A TH79776 A TH 79776A
Authority
TH
Thailand
Prior art keywords
acid
receptor antagonists
patients
salts
nycotinic
Prior art date
Application number
TH401001654A
Other languages
English (en)
Thai (th)
Original Assignee
นางดารานีย์ วัจนะวุฒิวงศ์ นางสาวสนธยา สังขพงศ์ นายณัฐพล อร่ามเมือง
Filing date
Publication date
Application filed by นางดารานีย์ วัจนะวุฒิวงศ์ นางสาวสนธยา สังขพงศ์ นายณัฐพล อร่ามเมือง filed Critical นางดารานีย์ วัจนะวุฒิวงศ์ นางสาวสนธยา สังขพงศ์ นายณัฐพล อร่ามเมือง
Publication of TH79776A publication Critical patent/TH79776A/th

Links

TH401001654A 2004-05-10 TH79776A (da)

Publications (1)

Publication Number Publication Date
TH79776A true TH79776A (da) 2006-09-07

Family

ID=

Similar Documents

Publication Publication Date Title
NZ595262A (en) Use of il-23 and il-27 antagonists to treat autoimmune ocular inflammatory disease
PE20040134A1 (es) Forma de dosificacion de una vez al dia de pramipexol
NO20070213L (no) Glucagon reseptorantagonister, fremstilling og terapeutiske anvendelser
CY1109624T1 (el) Υποκατεστημενα παραγωγα θειοφαινιου ως ανταγωνιστες υποδοχεα γλυκογονου, παρασκευη και θεραπευτικες χρησεις
NO20065878L (no) Terapeutiske forbindelser
RU2004135563A (ru) Лекарственное средство для лечения повышенной активности мочевого пузыря
SV2006002245A (es) 2-anilinopirimidinas sustituidas como inhibidores de la quinasa del ciclo celular o del receptor de la tirosina quinasa, su preparacion y su uso como medicamentos ref. p-sv-78.797/msu
BR0313388A (pt) Método para tratar, remediar ou evitar a psorìase em um paciente, uso de um composto de antagonista de cgrp, composição farmacêutica para tratamento da psorìase, e, método para identificar um composto candidato para o uso em um medicamento para tratar a psorìase
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
BRPI0921097A2 (pt) composto derivado de pirazol-3 carboxamida com atividade de antagonista de receptor 5-ht2b, agente preventivo ou terapêutico, composição farmacêutica e uso do composto ou seu sal farmaceuticamente aceitável e método ou prevenção ou tratamento.
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação
ES2286755T3 (es) Derivados de carboestirilo especificos com agonistas del subtipo de receptor 5-ht1a.
PE20040973A1 (es) Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroidales
JP2007119497A5 (da)
EP2032127A4 (en) TREATMENT OF PSYCHOLOGICAL ILLNESSES BY MEANS OF MUSCARIN RECEPTOR M1 ANTAGONISTS
BRPI0412430A (pt) polipeptìdeo agonista do receptor de zot e zonulina
RU2013112890A (ru) Терапевтическое применение 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазина
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
ATE473961T1 (de) Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung
WO2004026837A3 (en) Histamine h3 receptor antagonists, preparaton and therapeutic uses
TH79776A (da)
WO2005107752A3 (en) Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
BRPI0510855A (pt) medicamento em forma de pelìcula para ministração oral e uso de estriol e/ou de ésteres de estriol farmaceuticamente aceitáveis
WO2007047577A3 (en) Use of calcitonin-related peptide (cgrp) antagonists or release inhibitors for the treatment of sleep-related breathing disorders
WO2008000744A3 (en) 2-0'-methyladen0sine derivatives and their use as agonists or antagonists of an adenosine receptor